Praxis Precision Medicines, Inc.
PRAX
$48.78
$2.405.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 7.46M | 302.00K | 357.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 7.46M | 302.00K | 357.00K |
| Cost of Revenue | 63.01M | 60.81M | 56.29M | 41.88M | 27.26M |
| Gross Profit | -63.01M | -60.81M | -48.83M | -41.58M | -26.90M |
| SG&A Expenses | 13.06M | 13.92M | 15.13M | 15.26M | 10.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 76.07M | 74.73M | 71.42M | 57.14M | 37.85M |
| Operating Income | -76.07M | -74.73M | -63.96M | -56.84M | -37.49M |
| Income Before Tax | -71.13M | -69.30M | -58.68M | -51.91M | -32.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -71.13M | -69.30M | -58.68M | -51.91M | -32.68M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.13M | -69.30M | -58.68M | -51.91M | -32.68M |
| EBIT | -76.07M | -74.73M | -63.96M | -56.84M | -37.49M |
| EBITDA | -76.02M | -74.68M | -63.91M | -56.74M | -37.38M |
| EPS Basic | -3.31 | -3.29 | -2.94 | -2.75 | -1.74 |
| Normalized Basic EPS | -2.07 | -2.09 | -1.88 | -1.72 | -1.08 |
| EPS Diluted | -3.31 | -3.29 | -2.94 | -2.75 | -1.74 |
| Normalized Diluted EPS | -2.07 | -2.09 | -1.88 | -1.72 | -1.08 |
| Average Basic Shares Outstanding | 21.47M | 21.06M | 19.98M | 18.88M | 18.82M |
| Average Diluted Shares Outstanding | 21.47M | 21.06M | 19.98M | 18.88M | 18.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |